Epidemiological and Genomic Insights into SARS-CoV-2 in Lebanon: A Prospective Multicenter Analysis from 2020 to 2024 - Summary - MDSpire

Epidemiological and Genomic Insights into SARS-CoV-2 in Lebanon: A Prospective Multicenter Analysis from 2020 to 2024

  • By

  • Fatima Dakroub

  • Celina F. Boutros

  • Diego Teixeira

  • Habib Alkalamouni

  • Nagham Hamzah

  • Nancy Hourani

  • Amani Haddara

  • Samar Dalle

  • Dima Khreis

  • Elsy Tawil

  • Silma Baasiri

  • Zeinab El Zein

  • Mayse Naser

  • Rawan Korman

  • Maher Sraj

  • Yara Salameh

  • Sarah Merhi

  • Kawthar Faour

  • Nadim Tfaily

  • Stephanie Damaj

  • Mohammad Taleb

  • Soha Ghanem

  • Ghenwa Dakdouki

  • Rouba Shaker

  • Imad Chokr

  • David Breish

  • Maria Karam

  • Nada M. Melhem

  • Antoine Abou Fayad

  • Hassan Zaraket

  • Ewan M. Harrison

  • Ghassan M. Matar

  • Ghassan S. Dbaibo

  • January 28, 2026

  • 0 min

Share

Objective:

To compare clinical characteristics of COVID-19 across four years in Lebanon and identify risk factors associated with mortality, emphasizing the significance of these factors for public health.

Key Findings:
  • The pathogenicity of SARS-CoV-2 has evolved, impacting clinical outcomes, necessitating updated treatment protocols.
  • Variants such as Alpha, Delta, and Omicron have shown differing severity and hospitalization rates, highlighting the need for variant-specific strategies.
  • Immunity from infections and vaccinations has shifted COVID-19 from a pandemic to an endemic phase, indicating a need for ongoing surveillance.
Interpretation:

The study highlights the importance of genomic surveillance and understanding local epidemiological patterns to inform urgent public health strategies in Lebanon.

Limitations:
  • Limited data on the genomic epidemiology of SARS-CoV-2 in Lebanon prior to this study may affect the comprehensiveness of findings.
  • Potential biases in data collection due to reliance on patient self-reporting could impact the reliability of the results.
Conclusion:

Understanding the evolving dynamics of COVID-19 in Lebanon is crucial for effective management and vaccination strategies, underscoring the need for continued research.

Original Source(s)

Epidemiological and Genomic Insights into SARS-CoV-2 in Lebanon: A Prospective Multicenter Analysis from 2020 to 2024

  • by Fatima Dakroub, Celina F. Boutros, Diego Teixeira, Habib Alkalamouni, Nagham Hamzah, Nancy Hourani, Amani Haddara, Samar Dalle, Dima Khreis, Elsy Tawil, Silma Baasiri, Zeinab El Zein, Mayse Naser, Rawan Korman, Maher Sraj, Yara Salameh, Sarah Merhi, Kawthar Faour, Nadim Tfaily, Stephanie Damaj, Mohammad Taleb, Soha Ghanem, Ghenwa Dakdouki, Rouba Shaker, Imad Chokr, David Breish, Maria Karam, Nada M. Melhem, Antoine Abou Fayad, Hassan Zaraket, Ewan M. Harrison, Ghassan M. Matar, Ghassan S. Dbaibo

  • January 28, 2026

Related Content

Effectiveness of Telemedicine vs Face-to-Face Consultation in Fighting COVID-19: Retrospective Cohort Study of Adult Patients With COVID-19 in a Primary Care Setting

“Who’s on Backup?”—Exploring Internal Medicine Residency Backup Coverage Systems: Findings from a National Survey

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.